Science
Scientists use CRISPR-Cas9 to prevent Fuchs’ corneal dystrophy in mice – Medical Xpress
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used…
In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used start codon disruption with CRISPR-Cas9 gene editing to prevent Fuchs’ corneal dystrophy in mice. It is the first demonstrated…
Continue Reading
-
Noosa News11 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General20 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Business7 hours agoWhere next for the CBA share price?
-
General21 hours agoRed tape on chopping block in bid to build homes faster